Cargando…

Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients

Detalles Bibliográficos
Autores principales:	Jones, Can, Menchaca, Kristina, Ostos, Catherine, Durbin, Jeffery, Chen, Kai, Peles, Shachar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671509/ http://dx.doi.org/10.1182/blood-2022-157218

Ejemplares similares

Atraumatic Splenic Rupture: A Notable Complication of Rivaroxaban Use
por: Ostos Perez, Catherine A, et al.
Publicado: (2023)

PROTECTIVE INFLUENCE OF TOCILIZUMAB IN COVID-19 PATIENTS WITH CARDIAC ARRHYTHMIAS
por: Menchaca, Kristina, et al.
Publicado: (2023)

372. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study
por: Hachem, Ray Y, et al.
Publicado: (2020)

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

P1687: THROMBOEMBOLISM IN COVID-19 PATIENTS ON ECMO
por: Jones, C., et al.
Publicado: (2022)

An Unusual Case of Giant Abdominal Aortic Aneurysm Due to Type II Endoleak Persistent Failure
por: Ostos Perez, Catherine A, et al.
Publicado: (2022)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

Clinical Outcomes of Antipseudomonal vs. Non-Antipseudomonal Therapy in Patients with Osteomyelitis
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

370. Clinical Features and Outcomes of COVID-19 Infection Among Cancer Patients in Seattle, Washington
por: Yoke, Leah H, et al.
Publicado: (2020)

357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021)

398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States
por: Bauer, Karri A, et al.
Publicado: (2021)

48 Management and Disposition of Patients with Venous Thromboembolism In Academic Vs. Rural Hospital Populations During the COVID-19 Pandemic
por: Young, M.F., et al.
Publicado: (2021)

Prophylactic modalities against venous thromboembolism in complicated surgery for cancer patients
por: Salem, W, et al.
Publicado: (2008)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

1018. Bacterial Bioburden Characterization of Infected Diabetic Foot Ulcers in Hospitalized Patients in Association with Clinical Outcomes: Traditional Cultures vs. Molecular Sequencing Methods
por: Mudrik-Zohar, Hadar, et al.
Publicado: (2021)

509. Comparision of CD4+ T Cells in Patients with Severe vs Critical COVID -19
por: Gomez-Gomez, Brenda, et al.
Publicado: (2020)

Management Challenge: An Atypical Variant of Takotsubo Presenting With Multiple Complications
por: Menchaca, Kristina, et al.
Publicado: (2022)

Arterial Thromboembolism
Publicado: (2021)

Non pharmacological venous thromboembolism prophylaxis in old surgical patients
por: Apperti, M, et al.
Publicado: (2009)

1591. Infectious Outcomes of Levofloxacin Prophylaxis in Obese vs. Non-obese Patients with Hematologic Malignancies
por: Kurtti, Amanda, et al.
Publicado: (2018)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

219. Outcomes with Low- vs. High-bioavailability Oral Antibiotics in Treatment of Uncomplicated Gram-Negative Bacteremia
por: Cubillos, Ashley L, et al.
Publicado: (2021)

Incidence, risk factors and outcome of venous thromboembolism in critically ill obstetric patients
por: Kaddour, C, et al.
Publicado: (2008)

P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS
por: Masarova, Lucia, et al.
Publicado: (2023)

SEVERE HYPONATREMIA AS A MANIFESTATION OF A NEUROLOGIC DISORDER ASSOCIATED WITH THE COVID-19 VACCINE
por: MENCHACA, KRISTINA, et al.
Publicado: (2022)

311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19
por: Vrsaljko, Nina, et al.
Publicado: (2021)

Using rivaroxoban in patients with venous thromboembolism
por: Tyutrin, I, et al.
Publicado: (2015)

PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
por: Gutiérrez Ortiz de la Tabla, A., et al.
Publicado: (2021)

P1455: THROMBOEMBOLIC EVENTS IN SPLENECTOMISED VERSUS NON-SPLENECTOMISED THALASSEMIA PATIENTS: A META-ANALYSIS OF OBSERVATIONAL STUDIES
por: Vasileia Kalamara, Tsampika, et al.
Publicado: (2023)

950. Venous Thromboembolism in Persons Living with HIV (PLWH): A Single Center Retrospective Cohort Study
por: Chan, Kok Hoe, et al.
Publicado: (2020)

50. Comparative Incidence of Acute Kidney Injury in Septic Patients Treated with Vancomycin in Combination with Piperacillin/Tazobactam vs. Cefepime
por: Deja, Erin, et al.
Publicado: (2020)

1505. Antiviral and Antibiotic Prescribing Among Patients at an Ambulatory Cancer Center with Laboratory-Confirmed Influenza
por: Sorey, Woody, et al.
Publicado: (2020)

Reliability of electronic patient reported outcomes vs. clinical assessment
por: Krasteva, S., et al.
Publicado: (2023)

1082. Characterization of Ceftriaxone-Resistant Viridans Streptococci Bacteremia Among Patients at a Comprehensive Cancer Center
por: Marsland, Paula, et al.
Publicado: (2020)

PO-56 Relationship between clinical presentation of SARS-CoV-2 infection and risk of thromboembolic events and prognosis in cancer patients
por: Catoya Villa, J.L., et al.
Publicado: (2021)

P1667: ATTRIBUTES OF RANDOMIZED CONTROLLED TRIALS AND THEIR ASSOCIATIONS WITH FUNDING SOURCE IN VENOUS THROMBOEMBOLISM PROPHYLAXIS FOR PATIENTS WITH CANCER: A BIBLIOGRAPHICAL ANALYSIS
por: Zhao, Lucy, et al.
Publicado: (2023)

337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19
por: Pollett, Simon, et al.
Publicado: (2021)

Venous Thromboembolism in Patients Infected with Human Immunodeficiency Virus
por: Reddy, Archana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lca77q95isi9us3js66am5nlru